ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 416

Global Management of Patients with Knee Osteoarthritis Begins with Quality of Life Assessment: A Systematic Review

Josep Verges1, Marianna Vitaloni 1, Rosa Sciortino 2, Maritza Quintero 2, Marco Bibas 1, Jordi Monfort 3, Francisco de Abajo 4, Marco Matucci-Cerinic 5, Patrick du Souich 6, Ingrid Möller 7, Guy Eakin 8 and Angie Botto-van Bemden 8, 1Osteoarthritis International Foundation, Barcelona, Spain, 2De los Andes University, Merida, Venezuela, 3Hospital del Mar, Barcelona, Spain, 4Universidad de Alcalá, Madrid, Spain, 5University of Florence, Department of Medicine, Florence, Italy, Florence, Italy, 6University of Montreal, Montreal, Canada, 7Poal Institute, Barcelona, Spain, 8Arthritis Foundation, Atlanta

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Knee, osteoarthritis and patient health, patient outcomes, quality of life

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Patient Outcomes, Preferences, & Attitudes Poster I: Patient Reported Outcomes

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Knee OA (KOA) associates with remarkable functional restrictions due to pain that seriously affect social and emotional well-being, reducing the quality of life (QoL). The identification of therapies and factors that influence QoL in KOA patients may mitigate the clinical, economic, and social burden of this disease. Thus, the assessment of QoL in KOA, and individual factors associated has a great interest in research and clinical practice. Still, a general recompilation of these data is missing. Our aim was to recapitulate the existing information on QoL in KOA patients as an international tool to raise awareness on their condition and guide future actions for patient’s management.

Methods: We conducted a systematic review examining the breadth of the literature regarding the QoL in patients with KOA (up to 2017). We identify articles in MEDLINE, EMBASE, Cochrane, and PsycINFO using relevant. All articles were reviewed for inclusion by 3 independent reviewers. QoL domains and items relevant to patients with knee OA were extracted. Inclusion criteria were QoL compared to one or more demographic factors (age, gender), lifestyle factor (functional independence), or comorbidity factor diabetes, obesity) or a control group. The quality of included studies was assessed using a quality appraisal tool.

Results: We retrieved 610 articles, 62 fulfilled the inclusion criteria. The instrument used to assess QoL were SF-36 and EQ-5D. The participants’ mean in the studies was 561, the majority were female, the mean age was 63 years. KOA patients report a worse QoL compared to a control group, having women a worse QoL than men. Obesity, little or too much physical activity correlate with worse QoL. Higher educational level and mindfulness can improve QoL while poverty, physiological distress, depression and having dysfunctional families can reduce it. The delivery of a knee self-management program by health professionals can improve QoL. Surgical interventions result in good outcomes but the results were influenced by individual factors.

Conclusion: This is the first review pertaining to QoL in KOA patients. KOA has a strong impact on QoL. Individual factors (sex, weight, exercise, mental health, education) can influence QoL. These factors affect treatment outcomes and should be considered for a better patient’s management. These data are a valuable tool for health professionals, to better understand the disease and to implement a more adequate standard of care. This study was coordinated by representatives of patient organizations aiming to shed light on OA patient’s condition and the need for a broader evaluation of the individual and human factors affecting their QoL.


Disclosure: J. Verges, None; M. Vitaloni, None; R. Sciortino, None; M. Quintero, None; M. Bibas, None; J. Monfort, None; F. de Abajo, None; M. Matucci-Cerinic, Actelion, 2, 5, 8, Bayer, 5, 8, BMS, 2, 5, Chemomab, 5, J&J, 2, J&J, Janssen, Lilly, MSD, Pfizer, 5, 6, Lilly, 5, Pfizer, 5; P. du Souich, None; I. Möller, None; G. Eakin, Arthritis Foundation, 3, 6; A. Botto-van Bemden, None.

To cite this abstract in AMA style:

Verges J, Vitaloni M, Sciortino R, Quintero M, Bibas M, Monfort J, de Abajo F, Matucci-Cerinic M, du Souich P, Möller I, Eakin G, Botto-van Bemden A. Global Management of Patients with Knee Osteoarthritis Begins with Quality of Life Assessment: A Systematic Review [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/global-management-of-patients-with-knee-osteoarthritis-begins-with-quality-of-life-assessment-a-systematic-review/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/global-management-of-patients-with-knee-osteoarthritis-begins-with-quality-of-life-assessment-a-systematic-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology